期刊文献+

人酪氨酸酶抗原表位肽的表达、纯化及生物学活性分析 被引量:1

Expression, purification and biological activity analysis of the epitope peptide of human tyrosinase antigen
原文传递
导出
摘要 目的 探讨人酪氨酸酶抗原表位肽在白癜风患者自身抗体检测中的表达。方法 目的基因克隆至原核表达载体pGEX-4T-2,转化大肠杆菌BL21菌株,异丙基-β-D-硫代半乳糖苷(IPTG)诱导蛋白表达,通过SDS-PAGE分析和蛋白质印迹鉴定目的蛋白表达,ELISA检测其生物学活性。结果 成功构建重组表达载体,SDS-PAGE和蛋白质印迹结果表明,重组蛋白成功表达。应用凝胶分析系统分析蛋白表达量发现,目的蛋白的表达量占菌体总蛋白的90%。融合蛋白经过试剂盒纯化后,其蛋白纯度达95%以上。ELISA检测纯化蛋白的生物学活性,结果表明,纯化蛋白具有结合白癜风患者IgG的能力。结论 成功表达了人酪氨酸酶抗原表位肽,其表达蛋白具有生物学活性。 Objective To study the expression, purification and biological activity of the epitope peptide of human tyrosinase antigen. Methods The target gene, encoding the 240 - 300 epitope regions of human tyrosinase, was cloned to the prokaryotic expression vector pGEX-4T-2, which was then transfected into E coil BL21. The protein expression was induced by IPTG ( isopropyl-β-D-thiogalactoside ) and examined with SDS-PAGE and Western blotting. The biological activity of the target protein was detected with ELISA. The recombinant expression vector was constructed successfully. SDS-PAGE and Western blotting verified the successful expression of recombinant protein. Quantification by gel analysis system revealed that the recombinant protein amounted to 90% of the total protein content of the bacterial cells. With the application of glutathione S-transferase ( GST ) purification kit, the purity of the recombinant protein reached over 95%. The purified protein was confirmed by ELISA analysis to be able to bind to IgG from vitiligo patients. Conclusion Our results suggest that the epitope peptide of human tyrosinase antigen is expressed successfully, with biological activity confirmed.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2007年第3期139-142,共4页 Chinese Journal of Dermatology
基金 浙江省科技厅科技计划一般基金资助项目(2005C33017)
关键词 白癜风 一元酚单氧酶 原核表达 Vitiligo Monophenol monooxygenase Prokaryotic expression
  • 相关文献

参考文献11

  • 1Le Poole IC.van den Wijngaard RM.Westerhof W.et al.Presence or absence of melanoeytes in vitiligo lesions:an immunohis-tochemical investigation.J Invest Dermatal.1993,100(6):816-822.
  • 2Harning R,Cui J,Bystryn JC.Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo.J Invest Dermatol,1991,97(6):1078-1080.
  • 3Song YH.Gonnor E.Li Y.et al.The role of tyrosinase in autoimmune vitiligo.Lancet,1994,344(8929):1049-1052.
  • 4谢忠,季素珍,沈丽玉,朱学骏.白癜风抗原的辨认[J].中华皮肤科杂志,1995,28(4):226-227. 被引量:3
  • 5李强,高天文,李春英,卢涛,王秋枫.白癜风相关黑素细胞膜抗原的检测及分析[J].中华皮肤科杂志,2003,36(2):76-78. 被引量:15
  • 6Baharav E.Merimski O.Shoenfeld Y.et al.Tyrosinase as an autoantigen in patients with vitiligo.Clin Exp Immunol.1996,105(1):84-88.
  • 7Kemp EH.Waterman EA.Gawkrodger DJ.et al.Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay. Br J Dermatol,1998, 139(5): 798-805.
  • 8Kemp EH, Gawkrodger DJ, Watson PF, et al. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2). Clin Exp Immunol, 1997, 109(3): 495-500.
  • 9Kemp EH, Waterman EA, Gawkrodger DJ, et al. Identification of epitopes on tyrosinase which are recognized by autoantibodies from patients with vitiligo. J Invest Dermatol, 1999, 113 (2):267-271.
  • 10Kemp EH, Gawkrodger DJ, MacNeil S, et al. Detection of tyrosinase autoantibodies in patients with vitiligo using 35S-labeled recombinant human tyrosinase in a radioimmunoassay. J Invest Dermatol, 1997, 109(1): 69-73.

二级参考文献8

共引文献47

同被引文献11

  • 1贺秋豪,高天文,李春英,沈柱,王刚,杨军.白癜风患者血清自身抗体IgG识别人黑素浓集素受体-1B细胞表位的研究[J].中华皮肤科杂志,2005,38(1):29-31. 被引量:5
  • 2田艳丽,李春英,王刚,高天文,卢涛,李淼.In-cellPCR技术扩增白癜风自身抗体基因[J].中华皮肤科杂志,2006,39(1):38-40. 被引量:6
  • 3Farrokhi S, Hojjat-Farsangi M, Noohpisheh MK, et al. Assessment of the immune system in 55 Iranian patients with vitiligo. J Eur Acad Dermatol Venereol, 2005, 19(6): 706-711.
  • 4Song YH, Connor E, Li Y, et al. The role of tyrosinase in autoimmtme vitiligo.Lancet, 1994, 344(8929): 1049-1052.
  • 5Baharav E, Merimski O, Shoenfeld Y, et al. Tyrosinase as an auto-antigen in patients with vitiligo.Clin Exp lmmunol, 1996, 105 ( 1 ): 84-88.
  • 6Okamoto T, lrie RF, Fujii S, et al. Anti-tyrosinase-related protein- 2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol, 1998, 111(6): 1034-1039.
  • 7Howitz J, Brodthagen H, Schwartz M, et al. Prevalence of vitiligo. epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol, 1977, 113(1 ): 47-52.
  • 8Kemp EH, Gavalas NG, Gawkrodger D J, et al. Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo. Autoimmun Rev, 2007, 6(3 ): 138-142.
  • 9Harning R, Cui J, Bystryn JC. Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Derrnatol, 1991, 97(6): 1078-1080.
  • 10关翠萍,周妙妮,李永伟,尉晓冬,许爱娥.人酪氨酸酶抗原表位肽的表达、纯化及在白癜风患者中的抗原性检测[J].中华医学杂志,2007,87(34):2408-2411. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部